Status:

UNKNOWN

Comparison of Breast Milk Contents in Tandem Breastfeeding and Non-Tandem Breastfeeding Mother

Lead Sponsor:

Gazi University

Conditions:

Tandem Breastfeeding

Eligibility:

FEMALE

Phase:

NA

Brief Summary

Breastfeeding is the gold standard for feeding newborns and infants. Tandem breastfeeding is defined as breastfeeding during pregnancy or simultaneous breastfeeding of two non-twins. The aim of this s...

Detailed Description

There are studies on the concentration of macronutrients in breast milk in the literature A few studies have examined macronutrients in breast milk in mothers who breastfeed in tandem. Sinkiewicz-Daro...

Eligibility Criteria

Inclusion

  • Inclusion Criteria of Experiment Group:
  • If pregnant, being in the second trimester of pregnancy; have given birth, postpartum 16th day or more
  • If pregnant, not having a risky pregnancy
  • If she is pregnant, there is a report from the obstetrician she is followed that there is no harm in breastfeeding
  • The older child being breastfed is under the age of 2
  • Absence of literacy problems, mental disabilities and communication problems
  • Absence of chronic disease
  • No communicable disease
  • Not using a drug continuously
  • Not using any medication in the last 24 hours
  • Willingness to participate in the study
  • Inclusion Criteria of Control Group:
  • Postpartum 16th day and above
  • No risky pregnancy in her last pregnancy
  • Being multiparous
  • Absence of literacy problems, mental disabilities and communication problems
  • Absence of chronic disease
  • No communicable disease
  • Not using a drug continuously
  • Not using any medication in the last 24 hours
  • Willingness to participate in the study
  • Exclusion criteria. During the research process, mothers will be excluded from the sample in case the mothers want to leave the study, the sample milk is spoiled or there are losses during the analysis.

Exclusion

    Key Trial Info

    Start Date :

    April 15 2022

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    May 30 2022

    Estimated Enrollment :

    36 Patients enrolled

    Trial Details

    Trial ID

    NCT05338203

    Start Date

    April 15 2022

    End Date

    May 30 2022

    Last Update

    April 21 2022

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Sıdıka PELİT AKSU

    Ankara, Turkey/Ankara, Turkey (Türkiye), 06500